Founded in 2009, Deuteria Beverages has pioneered the discovery and use of ETHANOL-D in alcoholic beverages to reduce the known detrimental effects of ethanol such as hangovers, cirrhosis of the liver, stomach cancer, throat cancer, and Asian Flush Syndrome. Deuteria Beverages has been issued patents throughout the world teaching that 1-d2-ethanol ("Ethanol-D") slows the rate at which the human body converts ethanol to acetaldehyde, the 'bad actor' that leads to virtually all the side effects associated with alcohol consumption.